2022/ 2021/ 2020 / 2019 / 2018 / 2017 / 2016 / 2015 / 2014 / 2013 / 2012 / 2011 / 2010 / 2009 / 2008
12.21.2020 - Astrotech's Subsidiary 1st Detect Wins Gold at 'Astors' Homeland Security Awards as Best CBRNE Detection System
Astrotech Corporation (NASDAQ: ASTC) announced today that its 1st Detect subsidiary has received a Gold Award for its TRACER 1000 explosives trace detector (ETD) in the Best CBRNE Detection System category at American Security Today’s ‘ASTORS’ Homeland Security Awards program.
11.12.2020 - Astrotech Reports First Quarter of Fiscal Year 2021 Financial Results
Astrotech Corporation (NASDAQ: ASTC) reported its financial results for the first quarter of fiscal year 2021, which ended September 30, 2020. In October, we completed two strategic capital raises for a total of $24.2 million, strengthening our balance sheet for our future growth.
10.30.2020 - Astrotech Announces Closing of $6.2 Million Registered Direct Offering Priced At-the-Market
Astrotech Corporation (NASDAQ: ASTC), today announced that it has closed its previously announced registered direct offering priced at-the-market under Nasdaq rules of 2,887,906 shares of its common stock at a price of $2.15 per share for aggregate gross proceeds of $6.2 million.....
10.28.2020 - Astrotech Announces $6.2 Million Registered Direct Offering Priced At-the-Market
Astrotech Corporation (NASDAQ: ASTC), today announced that it has entered into definitive agreements with several institutional investors for the purchase and sale of 2,887,906 shares of Astrotech's common stock, at a purchase price of $2.15 per share, in a registered direct offering priced at-the-market under Nasdaq rules......
10.28.2020 - Astrotech's subsidiary 1st Detect Surpasses $1 Million in Purchase Orders
Astrotech Corporation (NASDAQ: ASTC) announced today that its 1st Detect subsidiary has exceeded $1 million in purchase orders and an additional $1 million in future service & support commitments for its TRACER 1000™ mass-spectrometry based explosives trace detector (ETD).
10.23.2020 - Astrotech Announces Closing of $18.0 Million Upsized Public Offering
Astrotech Corporation (NASDAQ: ASTC), today announced that it has closed its previously announced public offering of an aggregate of 7,826,086 shares of its common stock at a purchase price of $2.30 per share for aggregate gross proceeds of approximately $18.0 million.
10.22.2020 - Astrotech subsidiary and Cleveland Partner Broadcast
We are excited to announce that our subsidiary, BreathTech Corporation has partnered with Cleveland Clinic, a pioneer of many medical breakthroughs, to develop a non-invasive, rapid COVID-19 screening solution. Excited to share with you some of the highlights of the press coverage following BreathTech's announcement........
10.21.2020 -Astrotech Announces Pricing of $18.0 Million Upsized Public Offering
Astrotech Corporation (Nasdaq: ASTC), today announced the pricing of a public offering of an aggregate of 7,826,086 shares of common stock, at a purchase price of $2.30 per share of common stock. The closing of the public offering is expected to occur on or about October 23, 2020, subject to the satisfaction of customary closing conditions.
10.20.2020 - Astrotech Subsidiary and Cleveland Clinic Partner to Develop a Rapid COVID-19 Breath Test
Astrotech Corporation’s (NASDAQ: ASTC) subsidiary, BreathTech Corporation announced today that it has signed a joint development agreement (JDA) with Cleveland Clinic to explore leveraging Astrotech’s BreathTest-1000™ mass spectrometer to rapidly screen for COVID-19 or related indicators. The goal of the agreement is to develop a non-invasive device that will use breath samples to identify COVID-19 ..
09.09.2020 - 1st Detect's Tracer 1000™ Achieves Milestone in TSA Air Cargo Screening Qualification Test
Astrotech Corporation’s (NASDAQ: ASTC) 1st Detect subsidiary announced today that the TRACER 1000™ passed the U.S. Transportation Security Administration’s (TSA) Air Cargo Screening Technology Qualification Test’s (ACSQT) non-detection testing. In addition to non-detection testing, once the TRACER 1000 passes detection testing, it will be listed on the Air Cargo Screening Technology List (ACSTL) as an “approved” device and thereby approved for cargo sales in the United States.
09.04.2020 - Astrotech Reports Fiscal Year 2020 Financial Results
Astrotech Corporation (Nasdaq: ASTC) reported its financial results for the fiscal year ended June 30, 2020.
Fiscal year 2020 has been a pivotal year for Astrotech Corporation. We had the first sales of our TRACER 1000™ explosives trace detector (ETD), we completed a number of successful field trials including a live screening with the U.S. Transportation Security Administration (TSA) at Miami International Airport, and we signed a key contract with a global shipping and logistics company.
05.13.2020 - Astrotech Reports Third Quarter of Fiscal Year 2020 Financial Results
Astrotech Corporation (NASDAQ: ASTC) reported its financial results for the third quarter of fiscal year 2020, which ended March 31, 2020.
This quarter was pivotal for the Company, as we continued to generate interest for our new AgLAB-1000™ product that is being designed for process control and pesticide detection in the hemp and cannabis industries
03.30.2020 - Astrotech Announces Closing of $3.27 Million Registered Direct Offering Priced At-The-Market
03.27.2020 - Astrotech Announces $3.27 Million Registered Direct Offering Priced At-The-Market
03.27.2020 - Astrotech's BreathTest 1000 Confirmed to Detect Lung Disease Metabolites at Parts Per Billion
03.26.2020 - Astrotech Announces Closing of $1.77 Million Registered Direct Offering Priced At-the-Market
03.25.2020 - Astrotech Announces $1.77 Million Registered Direct Offering Priced At-the-Market
03.25.2020 - Bioworld™ Astrotech enters COVID-19 fight with screening instrument for lung diseases
Astrotech Corp., of Austin, Texas, has a broad range, having developed mass spectrometers in agriculture and manufacturing and selling chemical analyzers for use in the airport security and other applications. Now, it is looking to help in the fight against COVID-19.